1. Home
  2. YHC vs NXTS Comparison

YHC vs NXTS Comparison

Compare YHC & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc.

YHC

LQR House Inc.

HOLD

Current Price

$1.33

Market Cap

2.2M

ML Signal

HOLD

Logo Nexentis Technologies Inc. Common Stock

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$1.40

Market Cap

2.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
YHC
NXTS
Founded
2021
2009
Country
United States
Israel
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Agricultural Chemicals
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.4M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
YHC
NXTS
Price
$1.33
$1.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.4K
17.6K
Earning Date
04-15-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
8.28
N/A
Revenue
$1,120,622.00
$263,445.00
Revenue This Year
$1,267.57
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.16
N/A
Revenue Growth
86.42
N/A
52 Week Low
$0.02
$0.55
52 Week High
$2.72
$23.80

Technical Indicators

Market Signals
Indicator
YHC
NXTS
Relative Strength Index (RSI) 41.49 29.08
Support Level $1.27 $0.55
Resistance Level $2.20 $2.08
Average True Range (ATR) 0.09 0.13
MACD -0.03 -0.01
Stochastic Oscillator 24.00 13.84

Price Performance

Historical Comparison
YHC
NXTS

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: